More Articles Back to Article
FDA grants Inovio clearance for COVID-19 vaccine trial
Inovio Pharmaceuticals has received FDA clearance to launch its midstage trial to test its COVID-19 vaccine candidate INO-4800. The midstage portion of the trial will involve 400 participants across 17 clinical sites throughout the US. The Business Journals (tiered subscription model) (11/16)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!